Clinical Trial

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Name: 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — clinical trial record (NCT06864988)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Protocol Amendment History 1 change

notable Trial sites reduced: 100 -> 95 locations 2026-06-02

Trial Details

NCT Number	NCT06864988
Lead Sponsor	4D Molecular Therapeutics
Conditions	Macular Neovascularization Secondary to Age-Related Macular Degeneration
Enrollment	480 participants
Start Date	2025-03-03
Primary Completion	2027-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-01